Pay in 4 interest-free payments of $6.09 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
PSMA-targeted radionuclide therapy of metastatic castration-resistant prostate cancer with 177 Lu-labeled PSMA-617
Looking from 2023 to 2024, the latest year of data available, prescriptions and gross spending for Wegovy (first approved for obesity in 2021, approved for cardiovascular disease in 2024) and Mounjaro (approved for type 2 diabetes in 2022) more than doubled, and prescriptions and gross spending for Zepbound (first approved for obesity in 2023, approved for sleep apnea in 2024) increased more than fivefold
Roger H
An oral glucose tolerance test (OGTT) at the start and end of the study to see how glucose metabolism has changed
Be sure to avoid the delicate skin around the eyes unless the product specifically states it's safe for use in that area
The soft agar colony formation assay
US$ 24.72
US$ 27.53
US$ 21.42
US$ 24.01
US$ 27.66
US$ 29.62
US$ 27.69
